Second Approval in New Cholesterol Rx Class
Following the recent approval of a first-in-its-class cholesterol medication, a second treatment in this class received the green light from the FDA.
Second in New Cholesterol Rx Class Approved
The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.
On Your Feet for Heart Health
Will all the office couch potatoes please stand up? Your heart may thank you for it.
First-in-Class Cholesterol Rx Approved
A first-in-its-class injectable cholesterol medication just received the US Food and Drug Administration's (FDA) seal of approval.
Cholesterol Rx Gets FDA Nod
The U.S. Food and Drug Administration today approved Praluent (alirocumab) injection, the first cholesterol-lowering treatment approved in a new class of drugs known as proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors.
Are You at Risk for Heart Disease?
Heart disease remains the leading cause of death in the US, but watching for certain risk factors may help give your heart a chance.
What Statins Might Do for Lung Surgery Patients
A common cholesterol medication may make lung surgery a little bit safer.
Living up to Your Potential Life Span
No one lives forever. But you may be able to increase your life span.
When High Cholesterol Goes Under the Radar
Heart disease is one of the biggest health problems in the United States. And when adults don't know they have risk factors for heart disease, the problem becomes harder to address. That may be the case with at least one group of people in the US.
Statins and Memory Loss? Forget About It
One lifesaving drug may have even fewer side effects than previously thought.